Autoimmune hepatitis following transition from prednisolone to thrombopoietin receptor agonist therapy in immune thrombocytopenic purpura: A clinical precaution
PSL discontinuation likely unmasks underlying AIH in ITP patients, with TPO-RAs potentially modulating immune responses. Regular liver function monitoring is essential when transitioning ITP patients from PSL to TPO-RAs.
Authors
- Tamami Abe (ORCID: https://orcid.org/0000-0001-8314-7187)
- Yudai Fujiwara (ORCID: https://orcid.org/0000-0002-8436-5108)
- Yuichi Yoshida (ORCID: https://orcid.org/0000-0001-8855-4099)
- Akiko Suzuki (ORCID: https://orcid.org/0000-0003-3163-8093)
- Keisuke Kakisaka (ORCID: https://orcid.org/0000-0001-9627-138X)
- Hidekatsu Kuroda (ORCID: https://orcid.org/0000-0002-1471-1087)
- Tokio Sasaki (ORCID: https://orcid.org/0000-0002-2496-2584)
- Akio Miyasaka (ORCID: https://orcid.org/0000-0001-7747-5977)
- Kei Endo (ORCID: https://orcid.org/0000-0002-9698-2779)
- Takuya Watanabe (ORCID: https://orcid.org/0000-0003-4795-674X)
- Takayuki Matsumoto (ORCID: https://orcid.org/0000-0001-9786-3854)
- Kaname Inarimori
Institutions
- Iwate Medical University (JP)
Publication Details
- Journal
- Hepatology Research
- Published
- 2025-04-18
- DOI
- https://doi.org/10.1111/hepr.14198
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00